benchmark
Showing 1 - 25 of 756
Lung Cancer, Lung Non-Small Cell Carcinoma, Lung; Node Trial in Bologna (Tornado (Cook))
Recruiting
- Lung Cancer
- +2 more
- Tornado (Cook)
-
Bologna, Emilia Romagna, ItalyGian Piero Bandelli
Apr 5, 2023
COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)
Completed
- COVID-19
- Influenza
- Lucira COVID-19 & Flu Test
-
Cullman, Alabama
- +6 more
Nov 16, 2023
Atopic Diathesis, Eczema-prone Skin Trial in Schenefeld (Atopi intensive care BNO 3731, Benchmark product)
Completed
- Atopic Diathesis
- Eczema-prone Skin
- Atopi intensive care BNO 3731
- Benchmark product
-
Schenefeld, GermanySGS proderm GmbH
Mar 28, 2023
Atopic Diathesis, Eczema-Prone Skin Trial in Schenefeld (Lotion BNO 3732, Body Lotion Benchmark product)
Completed
- Atopic Diathesis
- Eczema-Prone Skin
- Lotion BNO 3732
- Body Lotion Benchmark product
-
Schenefeld, GermanySGS proderm GmbH
Mar 27, 2023
COVID-19 Trial in United States (NVX-CoV2373, SARS-CoV-2 rS antigen/Matrix-M Adjuvant)
Active, not recruiting
- COVID-19
- NVX-CoV2373
- SARS-CoV-2 rS antigen/Matrix-M Adjuvant
-
Austin, Texas
- +4 more
May 16, 2023
HIV Trial in Thika (co-formulated 25mg TAF/ 200mg FTC)
Recruiting
- HIV Infections
- co-formulated 25mg TAF/ 200mg FTC
-
Thika, KenyaKenya Medical Research Institute - Partners in Health Research a
Jan 24, 2023
Parkinson Disease Trial in Durham (Interdisciplinary Visit)
Completed
- Parkinson Disease
- Interdisciplinary Visit
-
Durham, North CarolinaDuke University
Apr 14, 2022
Low Back Pain Trial in Nashville (VR Pain Education, Usual Care Physical Therapy)
Completed
- Low Back Pain
- VR Pain Education
- Usual Care Physical Therapy
-
Nashville, TennesseeBelmont University
Feb 1, 2023
Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)
Completed
- Norovirus Infections
- VXA-GI.1.NN
- Placebo Tablet
-
Cypress, California
- +2 more
Sep 19, 2022
SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273.211
- +6 more
-
Sacramento, California
- +22 more
Nov 16, 2022
SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- Influenza
- mRNA-1073
- +3 more
-
Hollywood, Florida
- +13 more
Oct 5, 2022
COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))
Not yet recruiting
- COVID-19
- XBB.1.5 Vaccine (Booster)
- XBB.1.5 Vaccine (single dose)
-
Mobile, Alabama
- +29 more
Aug 4, 2023
HIV Trial in Thika (co-formulated 300 mg TDF/ 200mg FTC)
Enrolling by invitation
- HIV Infections
- co-formulated 300 mg TDF/ 200mg FTC
-
Thika, KenyaKenya Medical Research Institute - Partners in Health Research a
Jun 2, 2022
SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)
Recruiting
- SARS-CoV-2
- Influenza
- Fluarix
- +8 more
-
Chandler, Arizona
- +68 more
Apr 24, 2023
Commercial Typhoid Tests Validation Trial
Completed
- Typhoid Fever
- Rapid diagnostic tests
-
Nairobi, Kenya
- +1 more
May 23, 2022
Smoking Cessation Trial in Sacramento, Metairie, Austin (X-22 Smoking Cessation Product, Active Control Cigarettes)
Completed
- Smoking Cessation
- X-22 Smoking Cessation Product
- Active Control Cigarettes
-
Sacramento, California
- +2 more
Oct 21, 2021
Pneumococcal Vaccines Trial in United States (31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate
Recruiting
- Pneumococcal Vaccines
- 31 valent pneumococcal conjugate vaccine
- 20 valent pneumococcal conjugate vaccine
-
Mobile, Alabama
- +24 more
Nov 20, 2023
Acute Respiratory Infection, Telehealth Trial in Dallas (Trending Feedback, Benchmark Peer Comparison Feedback, Private
Enrolling by invitation
- Acute Respiratory Infection
- Telehealth
- Trending Feedback
- +3 more
-
Dallas, TexasTeladoc Health
Mar 28, 2022
Heart Failure Trial in Southampton (Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronisation Therapy
Not yet recruiting
- Heart Failure
- Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronisation Therapy Defibrillator (CRTD)
-
Southampton, Hampshire, United KingdomSouthampton Clinical Trials Unit
Oct 6, 2022
Pneumococcal Vaccines Trial in United States (24 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate
Active, not recruiting
- Pneumococcal Vaccines
- 24 valent pneumococcal conjugate vaccine
- 20 valent pneumococcal conjugate vaccine
-
Hollywood, Florida
- +12 more
Jul 25, 2022
Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant
Completed
- Influenza
- Influenza Immunization
- Influenza Hemagglutinin mRNA vaccine
- Quadrivalent Recombinant Influenza Vaccine
-
Rolling Hills Estates, California
- +19 more
Oct 31, 2023
Severe Traumatic Brain Injury Trial in Worldwide (ICP, CREVICE)
Not yet recruiting
- Severe Traumatic Brain Injury
- ICP
- CREVICE
-
Seattle, Washington
- +8 more
Oct 1, 2022